- Home
- IMPP vs INO Comparison
IMPP vs INO Comparison
Compare IMPP & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMPP | INO |
|---|---|---|
| Founded | 1981 | 1979 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 140.6M | 118.9M |
| IPO Year | N/A | 1999 |
Fundamental Metrics
Financial Performance| Metric | IMPP | INO |
|---|---|---|
| Price | $4.57 | $1.67 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $5.50 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 767.9K | 686.0K |
| Earning Date | 01-01-0001 | 06-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 54.18 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $42,220,086.00 |
| Revenue This Year | $7.55 | N/A |
| Revenue Next Year | $52.61 | $23,060.18 |
| P/E Ratio | $3.68 | ★ N/A |
| Revenue Growth | N/A | ★ 19.37 |
| 52 Week Low | $2.12 | $1.30 |
| 52 Week High | $6.57 | $2.86 |
Technical Indicators
Market Signals| Indicator | IMPP | INO |
|---|---|---|
| Relative Strength Index (RSI) | 59.60 | 44.82 |
| Support Level | $4.11 | $1.48 |
| Resistance Level | $4.79 | $1.78 |
| Average True Range (ATR) | 0.31 | 0.08 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 63.68 | 1.32 |
Price Performance
Historical ComparisonAbout IMPP Imperial Petroleum Inc.
Imperial Petroleum Inc is a provider of international seaborne transportation services to oil producers, refineries, and commodities traders. It owns and operates a fleet of six medium-range product tankers that carry refined petroleum products such as gasoline, diesel, fuel oil, and jet fuel, as well as edible oils and chemicals.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.